Freya Meds review
Three unambiguous commitment tiers (monthly $297/mo semaglutide and $390/mo tirzepatide, down to $150/$249 if you prepay a full year) with two named clinicians on the care team — though one is titled "Lead Physician" while described in the same breath as an NP, and the homepage anchors on the deepest-discount annual rate rather than the standing monthly price.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Freya Meds at a glance
- Semaglutide
- $297/mo
- Tirzepatide
- $390/mo
- Coverage
- All 50 states (claimed on-site; no exclusion list published)
- Brand-name
- Compounded only
How we scored Freya Meds
Each factor is scored from Freya Meds's real pricing, disclosures and oversight, then combined into the 55/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Limited public detail on who oversees care and how.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- freyameds.com
Independently verified 2026-08-04 by direct fetch of freyameds.com and its /pricing page (full checkout walkthrough not completed). Compounded-only: "Same active ingredient as Ozempic® and Wegovy®" (semaglutide) and "Same active ingredient as Mounjaro® and Zepbound®" (tirzepatide); no brand-name dispensing found. /pricing lays out three unambiguous, clearly labeled tiers per molecule: semaglutide Annual $150/mo, Quarterly $250/mo, Monthly $297/mo; tirzepatide Annual $249/mo, Quarterly $333/mo, Monthly $390/mo. The homepage headlines the Annual (deepest-commitment) rate as its marketing anchor ("Plans from as little as $150/month"); we headline the Monthly, no-prepay rate instead, per this network's rule against headlining a promo/deepest-commitment tier. Named clinicians: Dr. Sienna Steckel (titled "Lead Physician" in the role label but described in the same sentence as an NP with 8 years of GLP-1 management experience — a title inconsistency we flag rather than resolve) and Dr. Christopher Findley ("Consulting Physician," metabolic health, 6 years). Self-reported homepage claim: "450,000+ patients across 50 U.S. states" — a marketing claim, not independently verified. No state exclusion list found anywhere checked. No FDA warning letter / enforcement action found on the pages checked. The standard "not FDA-approved, compounded" disclaimer sentence was NOT found verbatim on Freya's own pages in this fetch — not asserted here.
What to expect when you sign up
We walked Freya Meds's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The /pricing page lays out three unambiguous, clearly labeled commitment tiers per molecule — Annual, Quarterly, Monthly — with no toggle-state guessing needed
- 2A "Meet Your Care Team" section on the homepage names two clinicians directly
- 3Per /pricing, every tier bundles unlimited doctor consultations, monthly group calls, and a one-on-one consultation with Freya's dietitian
What we noticed
- The homepage anchors on the Annual (12-month prepay) rate — "Plans from as little as $150/month" — while the real no-commitment monthly rate is $297/mo semaglutide, $390/mo tirzepatide, nearly double the advertised anchor
- One named clinician's title is inconsistent within her own bio: "Dr. Sienna Steckel" is labeled "Lead Physician" in the role heading but described in the same sentence as "an NP with 8 years of GLP-1 management and patient care experience" — we flag this rather than silently resolve it either way
- A second clinician, Dr. Christopher Findley, is named as "Consulting Physician," specializing in metabolic health
- "450,000+ patients across 50 U.S. states" is a self-reported marketing claim on the homepage, not independently verified beyond the site's own text
- The standard compounded/not-FDA-approved disclaimer sentence was not found verbatim on the pages we checked — we don't assert it was there without seeing it
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $297 | Monthly (no prepay) |
| Compounded semaglutide | $250 | Quarterly prepayPer-month rate when three months are paid up front. |
| Compounded semaglutide | $150 | Annual prepayPer-month rate when twelve months are paid up front. This is the rate the homepage headlines as "starting as low as $150/month" — the deepest-commitment tier, not the standard month-to-month rate. |
| Compounded tirzepatide | $390 | Monthly (no prepay) |
| Compounded tirzepatide | $333 | Quarterly prepayPer-month rate when three months are paid up front. |
| Compounded tirzepatide | $249 | Annual prepayPer-month rate when twelve months are paid up front — the homepage's marketing anchor, not the standing rate. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Freya Meds's public disclosures at last review and change often; confirm the current number on Freya Meds's own site.
What we like
- Three commitment tiers per molecule are unambiguously labeled on /pricing — no toggle-state guessing required to know what you're paying
- Unlimited doctor consultations, monthly group calls, and a one-on-one dietitian consultation are bundled at every tier, per the pricing page
- Names two clinicians directly by name rather than an anonymous "medical team"
- "Cancel anytime" is stated in plain language on the pricing page
The caveats
- The homepage headlines the $150/mo annual-prepay rate; the real no-commitment monthly price is nearly double, at $297/mo semaglutide and $390/mo tirzepatide
- "Lead Physician" Dr. Sienna Steckel is described in her own bio as an NP — a title inconsistency the site doesn't resolve
- "450,000+ patients across 50 U.S. states" is a self-reported claim, not independently verified
- No published state-exclusion list, so "50 states" can't be independently checked beyond the site's own text
Freya Meds for mothers: our verdict
Three unambiguous commitment tiers (monthly $297/mo semaglutide and $390/mo tirzepatide, down to $150/$249 if you prepay a full year) with two named clinicians on the care team — though one is titled "Lead Physician" while described in the same breath as an NP, and the homepage anchors on the deepest-discount annual rate rather than the standing monthly price. It runs about $150/month.
We weigh Freya Meds the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What Freya Meds actually costs
- Compounded semaglutide — Monthly (no prepay): $297/mo
- Compounded semaglutide — Quarterly prepay: $250/mo
- Compounded semaglutide — Annual prepay: $150/mo
- Compounded tirzepatide — Monthly (no prepay): $390/mo
- Compounded tirzepatide — Quarterly prepay: $333/mo
- Compounded tirzepatide — Annual prepay: $249/mo
That's roughly in line with the ~$155/month median across our roster.
The medications Freya Meds prescribes
Freya Meds prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Freya Meds fits — and where it doesn't — for mothers
A good fit if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you want frictionless cancellation — the fine print here is where the complaints cluster.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Freya Meds is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers comfortable prepaying a quarter or a year to bring the price down substantially, who don't mind confirming the Lead Physician's actual credential directly before they start.
Alternatives to Freya Meds
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Freya Meds
Head-to-head & alternatives
Freya Meds, answered
- Is Freya Meds really $150/month?
- $150/mo is the semaglutide price only if you prepay a full year up front — that's the number the homepage leads with. Pay quarterly and it's $250/mo; pay month to month with no commitment and it's $297/mo. Tirzepatide follows the same pattern: $249, $333, or $390 per month depending on how far ahead you pay. All three tiers are clearly labeled on the pricing page itself, so there's no guessing — just read past the homepage headline before you commit to a year.
- Is Freya Meds' "Lead Physician" actually a physician?
- Its own site isn't fully consistent on this. Dr. Sienna Steckel is titled "Lead Physician" in the care-team section's role heading, but the same sentence describes her as "an NP with 8 years of GLP-1 management and patient care experience." We're flagging the inconsistency rather than picking a side — worth asking directly before you sign up if the distinction matters to you.
Pricing, states and verification reflect Freya Meds's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.